Invention Grant
- Patent Title: Quinolone derivatives as fibroblast growth factor receptor inhibitors
-
Application No.: US16383237Application Date: 2019-04-12
-
Publication No.: US11078199B2Publication Date: 2021-08-03
- Inventor: Erik Verner , Kenneth Albert Brameld
- Applicant: Principia Biopharma, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Principia Biopharma, Inc.
- Current Assignee: Principia Biopharma, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Bryan Cave Leighton Paisner LLP
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/519 ; A61K45/06 ; C07D519/00 ; A61K31/5377 ; C07D487/04
Abstract:
Compounds that are Fibroblast Growth Factor Inhibitors (FGFR) and are therefore useful for the treatment of diseases treatable by inhibition of FGFR are disclosed. Also disclosed are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Public/Granted literature
- US20190233418A1 QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS Public/Granted day:2019-08-01
Information query
